At the cutting edge. G protein abnormalities in pituitary adenomas

Molecular and Cellular Endocrinology

Volumn 142, Issue 1-2, 1998, Pages 1-14

  Spada, Anna ^a   Lania, Andrea ^a   Ballarè, Emilia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

G proteins; Gsp; Phosphodiesterase; Pituitary adenomas

Indexed keywords

CYCLIC AMP; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; PHOSPHODIESTERASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENAL CORTEX TUMOR; ALBRIGHT SYNDROME; ARTICLE; CHROMOSOME 11Q; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HYPOPHYSIS ADENOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; ADENOMA; CHEMISTRY; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; MUTATION; PHYSIOLOGY; REVIEW;

ADENOMA; CYCLIC AMP; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GTP-BINDING PROTEINS; HUMANS; MUTATION; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0032566155     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00116-6     Document Type: Article

References (97)

1. Adams E.F., Brockmeier S., Friedmann E., Roth M., Buchfelder M., Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery. 33:1993;198-203.
2. Alexander J.M., Biller B.M.K., Bikkal H., Zervas N.T., Arnold A., Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Investig. 86:1990;336-340.
3. Alvaro V., Levy L., Dubray C., Roche A., Peillon F., Querat B., Joubert D. Invasive human pituitary tumors express a point mutated α-protein kinase-C. J Clin Endocrinol Metab. 77:1993;1125-1129.
4. Asa S.L., Kovacs K., Stefaneanu L., Horvath E., Billestrup N., Gonzalez-Mauchon C., Vale W. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology. 131:1992;2083-2089.
5. Ballarè E., Mantovani S., Bassetti M., Lania A., Spada A. Immunodetection of G proteins in human pituitary adenomas; evidence for a low expression of proteins of the Gi subfamily. Eur. J. Endocrinol. 137:1997;482-489.
6. Barbacid M. Ras gene. Annu. Rev. Biochem. 56:1987;779-827.
7. Bertherat J., Chanson P., Montminy M. The cyclic adenosine 3′, 5′ monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol. Endocrinol. 9:1995;777-783.
8. Billestrup N., Swanson L.W., Vale W. Growth hormone releasing factor stimulates cell proliferation of somatotrophs in vitro. Proc. Natl. Acad. Sci. USA. 83:1986;6854-6857.
9. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 348:1990;125-132.
10. Conti M., Jin C.S.L., Monaco L., Repaske D.R., Swinnen J.V. Hormonal regulation of cyclic nucleotide phosphodiesterase. Endocrine Rev. 12:1991;218-234.
11. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature. 350:1991;74-77.
12. Caccavelli L., Morange-Ramos I., Kordon C., Jaquet P., Enjalbert A. Alteration of Gα subunits mRNA levels in bromocriptine resistant prolactinomas. J. Neuroendocrinol. 8:1996;737-746.
13. Castrillo J.L., Theill L.E., Karin M. Function of homeodomain protein GHF1 in pituitary cell proliferation. Science. 253:1991;197-199.
14. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Dodelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weismann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., Marx S.J. Positional cloning of the gene for multiple neoplasia type 1. Science. 276:1997;404-407.
15. Chen R., Ingraham H.A., Treacy M.N., Albert V.R., Wilson L., Rosenfeld M.G. Autoregulation of pit 1 gene expression mediated by two cis-active promoter elements. Nature. 346:1990;583-586.
16. Chen C., Vincent J.D., Clarke I.J. Ion channels and signal transduction in the regulation of growth hormone secretion. Trends Endocrinol. Metab. 5:1994;227-233.
17. Chen Z.P., Xu S.U., Lightman S.L., Hall L., Levy A. Intracellular calcium ion in response to somatostatin in cells from human somatotroph adenomas. Clin. Endocrinol. (Oxford). 46:1997;45-53.
18. Civelli O., Bunzow J.R., Guan H.C. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 32:1993;281-307.
19. Clementi E., Malgaretti N., Meldolesi J., Taramelli R. A new constitutively activating mutation of the Gs protein α subunit-gsp oncogene is found in human pituitary tumours. Oncogene. 5:1990;1059-1061.
20. Conti M., Nemoz G., Sette C., Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev. 16:1995;370-389.
21. Cook S.J., McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 262:1993;1069-1072.
22. Cronin M.J., Valdenegro C.A., Perkins S.N., MacLeod R.M. The 7315α pituiatry tumor is refractory to dopaminergic inhibition of prolactin release but contains dopamine receptors. Endocrinology. 109:1981;2160-2166.
23. Derwahl M., Hamacher C., Russo D., Broecker M., Manole D., Schatz H., Kopp P., Filetti S. Constitutive activation of the Gsα protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J. Clin. Endocrinol. Metab. 81:1996;1898-1904.
24. Dhanasekaran N., Heasley L.E., Johnson G.L. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr. Rev. 16:1995;259-270.
25. Dumont J.E., Jauniaux J.C., Roger P.P. The cAMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14:1989;67-71.
26. Faccenda E., Melmed S., Bevan J.S., Eidne K.A. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas. Clin. Endocrinol. (Oxford). 44:1996;341-347.
27. Faure M., Bourne H.R. Differential effects of cAMP on the MAP kinase cascade; evidence for a cAMP-insensitive step that can bypass Raf-1. Mol. Biol. Cell. 6:1995;1025-1035.
28. Feig L.A. Guanine-nucleotide exchange factors: a family of positive regulators of ras and related GTPases. Curr. Opin. Cell. Biol. 6:1994;204-211.
29. Friedman E., Adams E.F., Hoog A., Gejman P.V., Carson E., Larsson C., DeMarco L., Werner S., Fahlbusch R., Nordenskjold M. Normal structural dopamine type 2 receptor gene in prolactin secreting and other pituitary tumors. J. Clin. Endocrinol. Metab. 78:1994;568-574.
30. Gaiddon C., Boutillier A.L., Monnier D., Mercken L., Loeffler J.P. Genomic effects of the putative oncogene Gαs: chronic transcriptional activation of c-fos protooncogene in endocrine cells. J. Biol. Chem. 36:1994;22663-22671.
31. Gaiddon C., Mercken L., Bancroft C., Loeffler J.P. Transcriptional effects in GH3 cells of Gsα mutants associated with human pituitary tumors: stimulation of adenosine 3′,5′-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A. Endocrinology. 136:1995;4331-4338.
32. Gejman P.V., Weinstein L.S., Martinez M., Spiegel A.M., Cao Q., Hseih W.T., Hoehe M.R., Gershon E.S. Genetic mapping of the Gs-α subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics. 9:1991;782-783.
33. Gupta S.K., Gallego C., Lowndes J.M., Pleiman C.M., Sable C., Eisfelder B.J., Jonhson G.L. Analysis of the fibroblast transformation potential of GTPase deficient gip 2 oncogenes. Mol. Cell. Biol. 12:1992;190-197.
34. Gupta S.K., Gallego C., Johnson G.L., Heasley L.E. MAP kinase is constitutively activated in gip2 and Src transformed Rat-1α fibroblasts. J. Biol. Chem. 267:1992;7987-7990.
35. Ham J., Ivan M., Wynford-Thomas D., Scanlon M.F. GH3 expressing constitutively active Gs alpha (Q227L) show enhanced hormone secretion and proliferation. Mol. Cell. Endocrinol. 127:1997;41-47.
36. Harris P.E., Alexander J.M., Bikkal H.A., Hsu D.W., Hedley-Whyte E.T., Klibansky A., Jameson J.L. Glycoprotein hormone α subunit production in somatotroph adenomas with and without Gsα mutations. J. Clin. Endocrinol. Metab. 75:1992;918-923.
37. Hashimoto K., Koga M., Motomura T., Kasayama S., Kouhara H., Ohnishi T., Arita N., Hayakawa T., Sato B., Kishimoto T. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary tumors. J. Clin. Endocrinol. Metab. 80:1995;2933-2939.
38. Herman V., Fagin J., Gonsky K., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab. 71:1990;1427-1433.
39. Hosoi E., Yokogoshi Y., Hosoi E., Horie H., Sano T., Yamada S., Saito S. Analysis of the Gsα gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-directed sequencing method using paraffin-embedded tissues. Acta Endocrinol. 129:1993;301-306.
40. Hunt T.W., Fields T.A., Casey P.J., Peralta E.G. RGS10 is a selective activator of Gαi GTPase activity. Nature. 383:1996;175-177.
41. Iiri T., Herzmark P., Nakamoto J.M., Van Dop C., Bourne H.R. Rapid GDP release from Gsα in patients with gain and loss of endocrine function. Nature. 371:1994;164-168.
42. Ikezu T., Okamoto T., Murayama Y., Homma Y., Ogata E., Nishimoto I. Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of gαi2. J. Biol. Chem. 269:1994;31955-31961.
43. Kaye P.V., Hapgood J., Millar R.P. Absence of mutations in exon 3 of the GnRH receptor in human gonadotroph adenomas. Clin. Endocrinol. 47:1997;546-554.
44. Landis C., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature. 340:1989;692-696.
45. Landis C.A., Harsh G., Lyons J., Davis R.L., McCormick F., Bourne H.R. Clinic characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J. Clin. Endocrinol. Metab. 71:1990;1416-1420.
46. Lania A., Persani L., Ballarè E., Mantovani S., Losa M., Spada A. Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J. Clin. Endocrinol. Metab. 83:1998;1624-1628.
47. Ledent C., Dumont J.E., Vassart G., Parmentier M. Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:1992;537-542.
48. Lin S., Lin C., Gukovsky I., Lusis A., Sawchenko P., Rosenfeld M.G. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature. 364:1993;208-213.
49. Lyons J., Landis C.A., Harsh G., Vallar L., Grunewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H.R., McCormick F. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
50. Ma Y.H., Landis C.A., Tchao N., Wang J., Rodd G., Hanapan D., Bourne H.R., Grodsky G.M. Constitutively active stimulatory G protein as in β cells of transgenic mice causes counteregulation of the increased adenosine 3′53-monophosphate and insulin secretion. Endocrinology. 134:1994;42-47.
51. Maenhaut C., Roger P.P., Reuse S., Dumont J.E. Activation of the cyclic AMP cascade as an oncogenic mechanism: the thyroid example. Biochimie. 73:1991;29-36.
52. Marshall C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Gen. Develop. 4:1994;82-89.
53. Michiels, F.M., Caillou, B., Dessarp-Freichey, F., Maunoury, M.T., Schlumberger, M., Mercken, L., Monier, R., Faunteuny, 1994. Oncogenic potential of guanine nucleotide stimulatory alpha subunit in thyroid glands of transgenic mice. Proc. Natl. Acad. Sci. USA 91, 10488-10492.
54. Montminy M.R., Gonzalez G.A., Yamamoto K.K. Regulation of cAMP-inducible genes by CREB. Trends Neurosci. 13:1990;184-188.
55. Muca C., Vallar L. Expression of mutationally activated Gαs stimulates growth and differentiation of thyroid FRTL 5 cells. Oncogene. 9:1994;3647-3653.
56. Nemoz G., Sette C., Hess M., Muca C., Vallar L., Conti M. Activation of cyclic nucleotide phosphodiesterase in FRTL-5 thyroid cells expressing a constitutively active Gsα Mol. Endocrinol. 9:1995;1279-1287.
57. Oyesiku N.M., Evans C.O., Brown M.R., Blevins L.S., Tindall G.T., Parks J.S. Pituitary adenomas; screening for Gαq mutations. J. Clin. Endocrinol. Metab. 82:1997;4184-4188.
58. O'Sullivan C., Barton C.M., Staddon S.L., Brown C.L., Lemoine N.R. Activating point mutations in the gsp oncogene in human thyroid adenomas. Mol. Carcinogen. 4:1991;345-349.
59. Pace A.M., Wong Y.H., Bourne H.R. A mutant α-subunit of Gip2 induces neoplastic transformationin RAT-1 cells. Proc. Natl. Acad. Sci. USA. 88:1991;7031-7035.
60. Parma J., Duprez L., Van Sande J., Couchaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:1993;649-651.
61. Parma J., Duprez L., Van Sande J., Hermans J., Rocmans P., Van Veiet G., Costagliola S., Rodien P., Dumont J.E., Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J. Clin. Endocrinol. Metab. 82:1997;2695-2701.
62. Patten J.L., Johns D.R., Valle D., Eil C., Gruppuso P.A., Steele G., Smallwood P.M., Levine M.A. Mutation in the gene encoding the stimulatory G protein of the adenylate cyclase in Albright's hereditary osteodystrophy. New Engl. J. Med. 322:1990;1412-1419.
63. Reincke M., Karl M., Travis W., Chrousos G.P. No evidence for oncogenic mutations in guanine-nucleotide binding proteins of human adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 77:1993;1419-1422.
64. Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocr. Rev. 16:1995;427-442.
65. Schiemann U., Assert R., Moskopp D., Gellner R., Hengst K., Gullotta F., Domschke W., Pfeiffer A. Analysis of a protein kinase C-α mutation in human pituitary tumours. J. Endocrinol. 53:1997;131-137.
66. + channel by G protein α-subunits. Nature. 380:1996;624-627.
67. Schwindinger W.F., Miric A., Zimmerman D., Levine M.A. A novel Gs α mutant in a patient with Albright's hereditary osteodystophy uncouples cell surface receptors from adenylyl cyclase. J. Biol. Chem. 269:1994;25387-25391.
68. Schwindinger W.F., Francomano C.A., Levine M.A. Identification of a mutation in the gene encoding the α subunit of the stimulatory G-protein of adenylyl cyclase in McCune-Albright syndrome. Proc. Natl. Acad. Sci. USA. 89:1992;5152-5156.
69. Shenker A. G protein-coupled receptor structure and function: the impact of disease-causing mutations. Thakker R.V. Bailliere's Clininical Endocrinology and Metabolism. 9(3):1995;427-451 Bailliere Tindall, London.
70. Shimon I., Melmed S. Genetic basis of endocrine disease: Pituitary tumor pathogenesis. J. Clin. Endocrinol. Metab. 82:1997;1675-1681.
71. Spada A., Arosio M., Bochicchio D., Bazzoni N., Vallar L., Bassetti M., Faglia G. Clinical, biochemical and morphological correlates in patients bearing growth hormone secreting tumors with or without constitutively active adenylyl cyclase. J. Clin. Endocrinol. Metab. 71:1990;1421-1426.
72. Spada A., Vallar L., Faglia G. G protein oncogenes in pituitary tumors. Trends Endocrinol. Metab. 3:1992;355-360.
73. Spada A., Vallar L., Faglia G. Cellular alterations in pituitary tumors. Eur. J. Endocrinol. 130:1994;43-52.
74. Spiegel A.M., Shenker A., Weinstein L.S. Receptor-effector coupling by G proteins: implications for normal and abnormal signal trasduction. Endocr. Rev. 13:1992;536-565.
75. Spiegel A.M. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J. Clin. Endocrinol. Metab. 81:1996;2434-2442.
76. Struthers R.S., Vale W.W., Arias C., Sawchenko P.E., Montminy M.R. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature. 350:1991;622-624.
77. Suarez H.G., Duvillard J.A., Caillu B., Schlumberger M., Parmentier C., Monier R. Gsp mutations in human thyroid tumours. Oncogene. 6:1991;677-679.
78. Thakker R.V., Pook M.A., Wooding C., Boscaro M., Scanarini M., Clayton R.N. Association of somatotrophinomas with loss of alleles on chromosome 11 and gsp mutations. J. Clin. Investig. 91:1993;2815-2821.
79. Tordjman K., Stern N., Ouaknine G., Yossiphov Y., Razon N., Nordenskjold M., Friedman E. Activating mutations of the Gs α-gene in nonfunctioning pituitary tumors. J. Clin. Endocrinol. Metab. 77:1993;765-769.
80. Vallar L., Spada A., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:1987;566-567.
81. Vallar L., Meldolesi J. Mechanisms of signal transduction at the D2 receptor. Trends Pharmacol. Sci. 10:1989;74-77.
82. van Biesen T., Luttrell L.M., Hawes B.E., Lefkowitz R.J. Mitogenic signaling via G protein coupled receptors. Endocr. Rev. 17:1996;698-714.
83. Yang I., Park S., Ryu M., Woo J., Kim S., Kim J., Kim K., Choi Y. Characteristics of gsp-positive growth hormone secreting pituitary tumors in Korean acromegalic patients. Eur. J. Endocrinol. 134:1996;720-726.
84. Yoshimoto K., Iwahana H., Fukuda A., Sano T., Itakura M. Rare mutations of the Gsα asubunit gene in human endocrine tumours. Cancer. 72:1993;1386-1393.
85. Warner D.R., Gejman P.V., Collins R.M., Weinstein L.S. A novel mutation adjacent to the switch III domain of Gs alpha in a patient with pseudohypoparathyroidism. Mol. Endocrinol. 11:1997;1718-1727.
86. Watson N., Linder M.E., Druey K.M., Kehrl J.H., Blumer K.J. RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunit. Nature. 383:1996;172-175.
87. Weinstein L.S., Shenker A., Gejman P., Marino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl. J. Med. 325:1991;1688-1695.
88. Williamson C.M., Schofield J., Dutton E.R., Seymour A., Beechey C.V., Edwards Y.H., Peters J. Glomerular-specific imprinting of the mouse Gsα gene; how does this related to hormone resistance in Albright hereditary osteodystrophy? Genomics. 36:1996;280-287.
89. Williamson E.A., Daniels M., Foster S., Kelly W.F., Kendall-Taylor P., Harris P.E. Gsα and Gi2α mutations in clinically non-functioning pituitary tumours. Clin. Endocrinol. 41:1994;815-820.
90. Williamson E.A., Ince P.G., Harrison D., Kendall-Taylor P., Harris P.E. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur. J. Clin. Investig. 25:1995;128-131.
91. Wilson L.C., Trembath R.C. Albright's hereditary osteodystrophy. J. Med. Genet. 31:1994;779-784.
92. Wong Y.H., Federman A., Pace A.M. et al. Mutant α subunits of Gi2 inhibit cAMP accumulation. Nature. 351:1991;63-65.
93. Wong Y.H., Chan J.S.C., Yung L.Y., Bourne H.R. Mutant α subunit of Gz transforms Swiss 3T3 cells. Oncogene. 10:1995;1927-1933.
94. Wood D.F., Johnston M., Johnston D.G. Dopamine, the dopamine D2 receptor and pituitary tumors. Clin. Endocrinol. (Oxford). 35:1991;455-466.
95. Xu N.Z., Voynoyasenetskaya T., Gutkind J.S. Potent transforming activity of the G(13) α subunit defines a novel family of oncogenes. Biochem. Biophys. Res. Commun. 201:1994;603-609.
96. Zachary I., Masters S.B., Bourne H.R. Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gsα Biochem. Biophys. Res. Commun. 168:1990;1184-1193.
97. Zhuang Z., Ezzat S., Vortmeyer A.O., Weil R., Oldfield E.H., Park W.S., Pack S., Huang S., Agarwal S.K., Guru S.C., Manickam P., Debelenko L.V., Kester M.B., Olufemi S.E., Heppner C., Crabtree J.S., Burns A.L., Spiegel A.M., Marx S.J., Chandrasekharappa S.C., Collins F.S., Emmert-Buck M.R., Liotta L.A., Asa S.L., Ludensky I.A. Mutations of the MEN 1 tumor suppressor gene in pituitary tumors. Cancer Res. 57:1997;5446-5451.